Scientific Letters
Vol. 18 No. 1 (2026): Mediterranean Journal of Hematology and Infectious Diseases
Acute Hemolytic Anemia Following Rasburicase in a Very Late Post-Transplant Relapse of Acute Myeloid Leukemia
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: September 4, 2025
Accepted: November 7, 2025
Accepted: November 7, 2025
36
Views
23
Downloads
Authors
Disease relapse is the first cause of death after allogeneic stem cell transplant, and it commonly occurs within the first 2 years after transplant. We describe the case of a patient with a very late post-transplant relapse of AML, whose therapy was complicated by an acute hemolytic anemia.
Downloads
Download data is not yet available.
Citations
How to Cite
“Acute Hemolytic Anemia Following Rasburicase in a Very Late Post-Transplant Relapse of Acute Myeloid Leukemia” (2026) Mediterranean Journal of Hematology and Infectious Diseases, 18(1), p. e2026003. doi:10.4084/MJHID.2026.003.
Copyright (c) 2026 Gianluca Cavallaro, Federico Lussana, Marco Frigeni, Maria Caterina Micò, Alessandra Algarotti, Anna Grassi, Orietta Spinelli, Chiara Pavoni, Elena Oldani, Alessandro Rambaldi
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
